Vanesa Gregorc
Candiolo, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 93 publications
Corrigendum to 'Real-life management of stage III non-small cell lung cancer patients in Italy: the BE-PACIFIC observational study' [Cancer Treat Res Commun. 2026:47:101143].
Journal: Cancer treatment and research communications
Published: August 25, 2026
Editorial: Integrating nutrition in cancer therapy: approaches to improve patient outcomes and survival.
Journal: Frontiers in oncology
Published: May 14, 2026
Primary results from EL1SSAR, a prospective phase IIIb study of first-line atezolizumab plus nab-paclitaxel therapy for patients with PD-L1-positive advanced triple-negative breast cancer.
Journal: Breast (Edinburgh, Scotland)
Published: March 11, 2026
HER2 Alterations in Non-Small Cell Lung Cancer: Emerging Perspectives on the Therapeutic Landscape.
Journal: International journal of molecular sciences
Published: January 28, 2026
Fulzerasib plus cetuximab in first-line KRASG12C-mutated non-small-cell lung cancer (KROCUS): a single-arm, multicentre, phase 1b/2 trial.
Journal: The Lancet. Oncology
Published: October 01, 2025
Real-world 5-year outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC.
Journal: ESMO open
Published: September 11, 2025
Why pay more for robot in breast surgery: literature review and analysis of costs.
Journal: Gland surgery
Published: August 05, 2025
Nutritional assessments and interventions in head and neck, esophageal, rectal and lung cancers undergoing anticancer treatments: a literature review.
Journal: Frontiers in oncology
Published: July 30, 2025
Survival Outcomes of Luminal Metastatic Breast Cancer Patients According to Changes in Molecular Subtype at Re-Biopsy: Insights from the GIM-13-AMBRA Study.
Journal: Cancers
Published: March 31, 2025
Real-life management of stage III non-small cell lung cancer patients in Italy: the BE-PACIFIC observational study.
Journal: Cancer treatment and research communications
Published: March 24, 2025
Validation of machine learning-based models to predict and explain the risk of ovarian cancer: a multicentric study on BRCA-mutated patients undergoing risk-reducing salpingo-oophorectomy.
Journal: Frontiers in oncology
Published: February 10, 2025
Adagrasib versus docetaxel in KRASG12C-mutated non-small-cell lung cancer (KRYSTAL-12): a randomised, open-label, phase 3 trial.
Journal: Lancet (London, England)
Published: January 20, 2025
Last Updated: 09/26/2026